CLINUVEL to advance novel pharmaceutical formulations in preclinical program
CLINUVEL PHARMS LTD S/ADR (CLVLY)
NASDAQ:AMEX Investor Relations:
clinuvel.com/investors
Company Research
Source: GlobeNewswire
Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug delivery platforms for peptides, melanocortinsaim to predict drug release kinetics from new formulationsliquid formulation allows flexible dosing through adjusting injection volumesperseverance during 10 years of in-house research MELBOURNE, Australia, Sept. 28, 2025 (GLOBE NEWSWIRE) -- CLINUVEL today announced that it is advancing new sustained-release liquid drug formulations in a preclinical program evaluating various drug release profiles. A decade of investment in fundamental research & development in CLINUVEL’s fully-owned Singaporean laboratories (VALLAURIX) has provided positive, consistent results demonstrating the potential for depot formulations to extend the duration of release of peptide drugs. Investment in novel drug delivery systems CLINUVEL’s formulation development has sought to lengthen the duration of time that peptides are detect
Show less
Read more
Impact Snapshot
Event Time:
CLVLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLVLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLVLY alerts
High impacting CLINUVEL PHARMS LTD S/ADR news events
Weekly update
A roundup of the hottest topics
CLVLY
News
- ASX Growth Stocks With High Insider Ownership [Yahoo! Finance]Yahoo! Finance
- CLINUVEL to advance novel pharmaceutical formulations in preclinical program [Yahoo! Finance]Yahoo! Finance
- Why Clinuvel Pharmaceuticals (ASX:CUV) Is Up 5.9% After Strong Earnings and NASDAQ ADR Expansion Plans – And What's Next [Yahoo! Finance]Yahoo! Finance